Pherecydes Pharma
Antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics.
Pherecydes Pharma has raised €2.0M across 1 funding round from 1 investor, most recently a Grant round in Jan 2022. Based in Romainville, France; active in Healthtech. Data as of 28 Oct 2026.
Romainville, Francewww.pherecydes-pharma.com/en ↗
Total raised
€2.0M
€2,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2022-01
latest 2022-01
Funding by year
EUR raised per yearPherecydes Pharma — funding by year — interactive chart.
Data table
| Pherecydes Pharma — funding by year | |
|---|---|
| 2022 | €2.0M |
Signals
High confidenceRaise-next likelihood8
base rate 45% for Grant
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-03 | Grant | €2.0M | Bpifrance | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData